UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

PloS one, 2015-12, Vol.10 (12), p.e0144856-e0144856

2015

Volltextzugriff (PDF)

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

PloS one, 2016-08, Vol.11 (8), p.e0160064-e0160064

2016

Volltextzugriff (PDF)

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

British journal of surgery, 2005-10, Vol.92 (10), p.1212-1220

2005

Volltextzugriff (PDF)

Fatal pulmonary embolism in hospitalised patients: a necropsy review

Journal of clinical pathology, 2004-12, Vol.57 (12), p.1254-1257

2004

Volltextzugriff (PDF)

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

PloS one, 2016-09, Vol.11 (9), p.e0163386-e0163386

2016

Volltextzugriff (PDF)

Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.940-941

2001

Volltextzugriff (PDF)

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619883946-1076029619883946

2019

Volltextzugriff (PDF)

An adaptive‐design dose‐ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1503-1510

2013

Volltextzugriff (PDF)

State of play and future direction with NOACs: An expert consensus

Vascular pharmacology, 2018-07, Vol.106, p.9-21

2018

Volltextzugriff (PDF)

Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran

Thrombosis research, 2009-01, Vol.123 (3), p.488-497

2009

Volltextzugriff (PDF)

Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART Study

Journal of thrombosis and haemostasis, 2005-01, Vol.3 (1), p.28-34

2005

Volltextzugriff (PDF)

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants

International journal of cardiology, 2018-10, Vol.269, p.174-181

2018

Volltextzugriff (PDF)

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Journal of thrombosis and haemostasis, 2003-12, Vol.1 (12), p.2490-2496

2003

Volltextzugriff (PDF)

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2015-09, Vol.13 (9), p.1665-1675

2015

Volltextzugriff (PDF)

Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case–control study

Journal of thrombosis and haemostasis, 2016-07, Vol.14 (7), p.1374-1383

2016

Volltextzugriff (PDF)

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Journal of thrombosis and haemostasis, 2014-04, Vol.12 (4), p.479-487

2014

Volltextzugriff (PDF)

Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery

British journal of surgery, 2005-11, Vol.92 (11), p.1335-1344

2005

Volltextzugriff (PDF)

The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders

Thrombosis research, 2015-02, Vol.135 (2), p.217-225

2015

Volltextzugriff (PDF)

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

The Lancet (British edition), 2008-01, Vol.371 (9609), p.315-321

2008

Volltextzugriff (PDF)

Response to “Letter to the Editor concerning: ‘A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants’”

International journal of cardiology, 2020-05, Vol.306, p.101-101

2020

Volltextzugriff (PDF)

Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England

Pulmonary circulation, 2018-07, Vol.8 (3), p.1-10

2018

Volltextzugriff (PDF)

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery

The Lancet (British edition), 1993-01, Vol.341 (8840), p.259-265

1993

Volltextzugriff (PDF)

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Thrombosis research, 2018-10, Vol.170, p.165-174

2018

Volltextzugriff (PDF)

Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1913-1922

2017

Volltextzugriff (PDF)

Pulmonary artery catheterization and mortality in critically ill patients

British Journal of Anaesthesia, 2000-10, Vol.85 (4), p.611-615

2000

Volltextzugriff (PDF)

1 – 25 von 320.507

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212.069)
Mit Volltextzugriff
(246.034)

Publikationsform

12 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(307.778)
Französisch
(11.299)
Hebräisch
(634)
Japanisch
(372)
Deutsch
(260)
Spanisch
(209)
Portugiesisch
(122)
Niederländisch
(90)
Russisch
(76)
Koreanisch
(37)
Italienisch
(26)
Chinesisch
(15)
Tschechisch
(13)
Ungarisch
(12)
Polnisch
(11)
Croatian
(10)
Katalanisch
(8)
Latein
(8)
Arabisch
(7)
Norwegisch
(6)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(119.084)
Life Sciences & Biomedicine
(89.324)
Humans
(73.534)
Female
(38.279)
Male
(36.226)
Biological And Medical Sciences
(26.663)
Adult
(22.325)
Medical Sciences
(20.002)
Animals
(19.585)
Middle Aged
(19.177)
Physical Sciences
(19.088)
Social Sciences
(17.508)
Technology
(14.758)
Aged
(14.033)
Adolescent
(9.322)
Physics
(9.205)
Neurosciences & Neurology
(8.912)
Child
(8.276)
General & Internal Medicine
(8.144)
Psychology
(7.893)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(92.975)
EZB Electronic Journals Library
(92.863)
IngentaConnect
(92.654)
Journals@Ovid Ovid Full Text
(76.618)
Publisher website
(73.251)
Elsevier ScienceDirect Journals Complete
(46.895)
JSTOR
(34.288)
IngentaConnect Journals
(31.663)
Wiley Online Library
(30.470)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(29.411)
Nexis Uni
(26.590)
Ebook Central Perpetual and DDA
(24.569)
eBooks on EBSCOhost
(21.123)
Wiley Online Library Full Collection 2018
(19.803)
EBSCOhost Business Source Ultimate
(16.657)
Springer journals
(14.014)
Oxford journals
(11.283)
Taylor & Francis Current Content Access
(10.124)
Taylor & Francis:Master (3349 titles)
(9.742)
Taylor & Francis Journals Auto-Holdings Collection
(9.592)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The New York Times
(4.411)
Science
(2.568)
New York Times
(1.806)
National Journal
(1.628)
Plos One
(1.469)
Journal Of Clinical Oncology
(1.393)
Blood
(1.264)
The Journal Of Biological Chemistry
(1.255)
Journal Of The American College Of Cardiology
(1.246)
Wwd
(1.242)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

Fatal pulmonary embolism in hospitalised patients: a necropsy review

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

An adaptive‐design dose‐ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery

State of play and future direction with NOACs: An expert consensus

Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran

Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART Study

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case–control study

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery

The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

Response to “Letter to the Editor concerning: ‘A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants’”

Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis

Pulmonary artery catheterization and mortality in critically ill patients

Suchergebnisse filtern